Immunodiagnostic Systems Holdings plc (IDH) - Product Pipeline Analysis, 2013 Update

Immunodiagnostic Systems Holdings pl...
ids-isys Mgp Assay Product Description 21
ids-isys Osteocalcin Kit 22
ids-isys Osteocalcin Kit Product Status 22
ids-isys ...
Upcoming SlideShare
Loading in …5
×

Immunodiagnostic Systems Holdings plc (IDH) - Product Pipeline Analysis, 2013 Update:New Industry Analysis Report

64 views

Published on

Immunodiagnostic Systems Holdings plc (IDH) - Product Pipeline Analysis, 2013 Update:New Industry Analysis Report
@ http://www.researchmoz.us/immunodiagnostic-systems-holdings-plc-idh-product-pipeline-analysis-2013-update-report.html

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
64
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Immunodiagnostic Systems Holdings plc (IDH) - Product Pipeline Analysis, 2013 Update:New Industry Analysis Report

  1. 1. Immunodiagnostic Systems Holdings plc (IDH) - Product Pipeline Analysis, 2013 Update Immunodiagnostic Systems Holdings plc (IDS) is a diagnostic product company. The company designs, develops, and supplies immunoassays, immunoassay kits, and automated immunoanalyser technologies. Its products include automated IDS-iSYS system, IDS-iSYS cartridge checking system IDS-iSYS 1,25-Dihydroxy vitamin D, IDS-iSYS 1,25-Dihydroxy vitamin D controls, BoneTRAP ELISA, vitamin D calibration verifiers, and IDS-iSYS intact PTH. IDS offer products in the fields of osteoporosis, rheumatoid and osteoarthritis, renal and cardiovascular disease. The company serves the needs of clinical and research laboratories. It markets products in Spain, Italy, Australia, and Japan. The company operates in the UK, Germany, France, Norway, Belgium and the US. IDS is headquartered in Boldon, the UK. This report is a source for data, analysis and actionable intelligence on the Immunodiagnostic Systems Holdings plc portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date. Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Scope Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments. Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase. Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date. Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application. Data on relevant clinical trials and product patent details, wherever applicable. Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility. Reasons to Buy Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally. Design and develop your product development, marketing and sales strategies. Exploit M&A opportunities by identifying market players with the most innovative pipeline. Develop market-entry and market expansion strategies. Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return. Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc. Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize. table Of Contents table Of Contents 2 list Of Tables 4 list Of Figures 4 immunodiagnostic Systems Holdings Plc - Business Description 5 key Facts 6 immunodiagnostic Systems Holdings Plc - Major Products And Services 7 immunodiagnostic Systems Holdings Plc Pipeline Products By Equipment Type 8 immunodiagnostic Systems Holdings Plc Pipeline Products By Development Stage 10 immunodiagnostic Systems Holdings Plc Pipeline Products By Therapy Area 12 ids-isys - Acth Assay 14 ids-isys - Acth Assay Product Status 14 ids-isys - Acth Assay Product Description 14 ids-isys Aldosterone Assay 15 ids-isys Aldosterone Assay Product Status 15 ids-isys Aldosterone Assay Product Description 15 ids-isys Bap Assay 16 ids-isys Bap Assay Product Status 16 ids-isys Bap Assay Product Description 16 ids-isys Bioactive Pth (1-84) Kit 17 ids-isys Bioactive Pth (1-84) Kit Product Status 17 ids-isys Bioactive Pth (1-84) Kit Product Description 17 ids-isys Bonetrap (tracp 5b) Elisa Kit 18 ids-isys Bonetrap (tracp 5b) Elisa Kit Product Status 18 ids-isys Bonetrap (tracp 5b) Elisa Kit Product Description 18 ids-isys Cortisol Assay 19 ids-isys Cortisol Assay Product Status 19 ids-isys Cortisol Assay Product Description 19 ids-isys Mark Ii 20 ids-isys Mark Ii Product Status 20 ids-isys Mark Ii Product Description 20 ids-isys Mgp Assay 21 ids-isys Mgp Assay Product Status 21 Immunodiagnostic Systems Holdings plc (IDH) - Product Pipeline Analysis, 2013 Update
  2. 2. ids-isys Mgp Assay Product Description 21 ids-isys Osteocalcin Kit 22 ids-isys Osteocalcin Kit Product Status 22 ids-isys Osteocalcin Kit Product Description 22 ids-isys P1np Assay 23 ids-isys P1np Assay Product Status 23 ids-isys P1np Assay Product Description 23 ids-isys Renin Assay 24 ids-isys Renin Assay Product Status 24 ids-isys Renin Assay Product Description 24 immunodiagnostic Systems Holdings Plc - Key Competitors 25 immunodiagnostic Systems Holdings Plc - Key Employees 26 immunodiagnostic Systems Holdings Plc - Locations And Subsidiaries 27 head Office 27 other Locations & Subsidiaries 27 recent Developments 28 immunodiagnostic Systems Holdings Plc, Recent Developments 28 apr 09, 2013: Immunodiagnostic Systems And Oxford Biosystems Collaborate For Sale And Marketing Of All Manual Assays In Uk 28 appendix 29 methodology 29 about Globaldata 29 contact Us 29 disclaimer 29 ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price. Contact: M/s Sheela, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-997-4948 Email: sales@researchmoz.us Website: http://www.researchmoz.us/ Immunodiagnostic Systems Holdings plc (IDH) - Product Pipeline Analysis, 2013 Update

×